Improving cancer care for older adults with gastrointestinal cancers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research focuses on enhancing cancer care for older adults diagnosed with gastrointestinal malignancies by integrating geriatric consultations into their treatment plans. The study is structured in three phases: the first phase assesses the needs of older patients and caregivers, while the second phase involves a pilot intervention to implement the proposed care model. The third phase will expand the clinical trial based on the findings from the initial phases. The goal is to refine and improve the care provided to this vulnerable population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who are age 65+ at time of initial consult at DF/BWCC
* Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors.
* Continuing care at DF/BWCC beyond initial consult visit

Exclusion Criteria:

* Patients less than age 65 at time of initial consultation appointment with DF/BWCC.
* Patients who are not continuing care at DF/BWCC beyond first consult visit.
* Not proficient in English, Spanish, Haitian Creole, Portuguese, Traditional Chinese, Arabic, or Russian
* Patient who are not considered appropriate for enrollment due to complex medical, social, or other situation as determined by their primary oncology team.
* Participants with psychiatric illness/social situations that would limit compliance with study requirements.

Where it's running

• Dana-Farber Cancer Institute
  Boston, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Nadine A Jackson, MD, MPH — Dana-Farber Cancer Institute
• Study coordinator: Nadine A Jackson, MD, MPH
• Email: NA_Jackson@dfci.harvard.edu
• Phone: 877-442-3324

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Virtual exercise program to preserve function and prevent disability during chemotherapy

  This trial tests whether supervised resistance sessions by video plus short home aerobic workouts help adults 18–64 maintain strength and stay active while receiving curative-intent chemotherapy.

  Recruiting at 29 sites Alliance for Clinical Trials in Oncology · Dublin, California and 29 other locations · NCT07059884

• Testing MDX2001 for advanced solid tumors

  This study is testing a new drug called MDX2001 to see if it can safely help people with advanced solid tumors like breast or colon cancer.

  Recruiting at 6 sites Phase 1/2 ModeX Therapeutics, An OPKO Health Company · Denver, Colorado and 5 other locations · NCT06239194

• Using modified immune cells to target specific cancer mutations

  This study is testing a new treatment that uses modified immune cells to target and attack tumors with a specific cancer mutation in patients with advanced pancreatic and colorectal cancer.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT03190941

• A resource for collecting cancer data and biospecimens

  This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.

  Recruiting at 42 sites University of Nebraska · Greenwood Village, Colorado and 41 other locations · NCT02012699

• CEA-targeted CAR-T for advanced CEA-positive solid tumors

  This trial will try CEA-targeted CAR-T cell infusions in adults with advanced CEA-positive cancers (such as colorectal, gastric, esophageal, lung, or pancreatic cancer) to see if the treatment is safe and helps control the disease.

  Recruiting Phase 1 Chongqing Precision Biotech Co., Ltd · Hefei, Anhui · NCT07179692

• Using brodalumab to treat immune-related side effects from cancer therapy

  This study is testing if brodalumab can help cancer patients who are having immune-related side effects from their immunotherapy treatment feel better.

  Recruiting Phase 1 Columbia University · New York, New York · NCT06673329

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.